ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 646005 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 646005; 2) Community: the network communities that were significantly associated with the response to NSC 646005; 3) Molecule: the relationships between components within communities and NSC 646005; 4) MDR: the compounds that were significantly associated with the NSC 646005.

NSC Compound Enrichment Correlation
NSC 753377 3-[2-(1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.012942183459279 0.61095236
NSC 753456 2-4-[5-(3,5-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,6,7-trimethoxy-1,3-benzothiazole 0.012942183459279 0.4338043
NSC 753598 Null 0.012942183459279 0.26710088
NSC 753661 methyl ester prodigiosene 0.012942183459279 0.37988511
NSC 761832 (Z)-3-((1-(3,5-dimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)-5-methoxyindolin-2-one 0.012942183459279 0.33524055
NSC 762908 2-(4-(methylsulfonyl)phenyl)-6-p-tolyl-4,5-dihydropyridazin-3(2H)-one 0.012942183459279 0.59966643
NSC 85561 3-hydroxy-4-((1-hydroxynaphthalen-2-yl)diazenyl)-7-nitronaphthalene-1-sulfonic acid, sodium sallt 0.012942183459279 0.19179314
NSC 298223 Antibiotic CC 1065 (9CI) 0.0133012546828912 0.19981847
NSC 636373 Null 0.0133012546828912 0.20758077
NSC 641390 Null 0.0133012546828912 0.4063337
Total:125  Current:53    [First] [Prev] [Next] [Last]